Can explicit suggestions about the harmfulness of EMF exposure exacerbate a nocebo response in healthy controls?

While there has been consistent evidence that symptoms reported by individuals who suffer from Idiopathic Environmental Intolerance attributed to Electromagnetic Fields (IEI-EMF) are not caused by EMF and are more closely associated with a nocebo effect, whether this response is specific to IEI-EMF sufferers and what triggers it, remains unclear. The present experiment tested whether perceived EMF exposure could elicit symptoms in healthy participants, and whether viewing an 'alarmist' video could exacerbate a nocebo response. Participants were randomly assigned to watch either an alarmist (N = 22) or control video (N = 22) before completing a series of sham and active radiofrequency (RF) EMF exposure provocation trials (2 open-label, followed by 12 randomized, double-blind, counterbalanced trials). Pre- and post-video state anxiety and risk perception, as well as belief of exposure and symptom ratings during the open-label and double-blind provocation trials, were assessed. Symptoms were higher in the open-label RF-ON than RF-OFF trial (p < .001). No difference in either symptoms (p = .183) or belief of exposure (p = .144) was observed in the double-blind trials. Participants who viewed the alarmist video had a significant increase in symptoms (p = .041), state anxiety (p < .01) and risk perception (p < .001) relative to the control group. These results reveal the crucial role of awareness and belief in the presentation of symptoms during perceived exposure to EMF, showing that healthy participants exhibit a nocebo response, and that alarmist media reports emphasizing adverse effects of EMF also contribute to a nocebo response.

Clarifying the functional process represented by P50 suppression.

P50 suppression refers to the amplitude-reduction of the P50 event related potential to the second (S2) relative to the first (S1) of identical auditory stimuli presented 500ms apart. Theory suggests that refractory periods (RPs) and/or inhibitory inputs (II) underlie P50 suppression. The present study manipulated interval between stimulus pairs (IPI: 2, 8s) and direction of participants' attention (Attention, Non-Attention) in order to determine which theory best explains P50 suppression. The rationale is that: 1/ RP and II predict opposite effects of manipulating the functionality of the mechanism responsible for S2P50 suppression (e.g. reducing function would increase S2P50 according to the II and decrease S2P50 according to the RP hypothesis); 2/ IPI2 (relative to IPI8) will reduce functionality of the mechanism responsible for S2P50 suppression, as it results in less recovery of (and a greater challenge to) that mechanism - RP would thus predict reduced S2P50, whereas II would predict enhanced S2P50 amplitude; and 3/ where the mechanism responsible for S2P50 suppression is challenged (i.e. at IPI2, due to insufficient recovery), Attention (relative to Non-Attention) will enhance functionality of this mechanism - RP would thus predict increased S2P50, whereas II would predict reduced S2P50 amplitude. In the Non-Attention paradigm, reducing IPI from 8 to 2s tended to increase S2P50 amplitude (and consequently impaired P50 suppression), and in the 2s IPI paradigm, directing attention towards the stimuli reduced S2P50 amplitude (and improved P50 suppression), with both effects supporting the II hypothesis only.

Chronic effects of cannabis on sensory gating.

Chronic cannabis use has been associated with neurocognitive deficits, alterations in brain structure and function, and with psychosis. This study investigated the effects of chronic cannabis use on P50 sensory-gating in regular users, and explored the association between sensory gating, cannabis use history and the development of psychotic-like symptoms. Twenty controls and 21 regular cannabis users completed a P50 paired-click (S1 and S2) paradigm with an inter-pair interval of 9s. The groups were compared on P50 amplitude to S1 and S2, P50 ratio (S2/S1) and P50 difference score (S1-S2). While cannabis users overall did not differ from controls on P50 measures, prolonged duration of regular use was associated with greater impairment in sensory gating as indexed by both P50 ratio and difference scores (including after controlling for tobacco use). Long-term cannabis users were found to have worse sensory gating ratios and difference scores compared to short-term users and controls. P50 metrics did not correlate significantly with any measure of psychotic-like symptoms in cannabis users. These results suggest that prolonged exposure to cannabis results in impaired P50 sensory-gating in long-term cannabis users. While it is possible that these deficits may have pre-dated cannabis use and reflect a vulnerability to cannabis use, their association with increasing years of cannabis use suggests that this is not the case. Impaired P50 sensory-gating ratios have also been reported in patients with schizophrenia and may indicate a similar underlying pathology.

An evaluation of P50 paired-click methodologies.

The utility of P50 paired-click measures is limited by their unestablished reliability, unknown effects of time, and long protocol. This study measured within-session reliability, temporal course, effect of varying interpair interval (IPI), and peak definition and ratio calculation methods on P50 paired-click measures in healthy participants. Results indicate higher reliability for difference (ICC=.72) than ratio (ICC=.44) method; when P50 peaks are defined as baseline-to-peak than peak-to-peak; time-related changes; and comparable P50 paired-click measures at long (9 s) and short (3-7 s) IPIs. After controlling for time effects, P50 paired-click measures are relatively reliable within-session and are best measured using the difference method and defined as baseline-to-peak amplitude; time effects must be taken into account when measuring P50 paired-click measures in a long paradigm; and IPI can be shortened in studies with healthy samples.